(Q34561653)

English

Multidimensional effects of sertraline in social anxiety disorder

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Multidimensional effects of sertraline in social anxiety disorder (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1 reference

based on heuristic

inferred from title

author name string

Kathryn M Connor

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Jonathan R T Davidson

2

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Henry Chung

3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Ruoyong Yang

4

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Cathryn M Clary

5

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

publication date

1 January 2006

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Depression and Anxiety

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

23

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

6-10

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

1 reference

https://api.crossref.org/works/10.1002%2FDA.20086

21 January 2018

Agoraphobia, simple phobia, and social phobia in the National Comorbidity Survey

1 reference

https://api.crossref.org/works/10.1002%2FDA.20086

21 January 2018

Paroxetine in social phobia/social anxiety disorder. Randomised, double-blind, placebo-controlled study. Paroxetine Study Group

1 reference

https://api.crossref.org/works/10.1002%2FDA.20086

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperhidrosis in social anxiety disorder

1 reference

https://api.crossref.org/works/10.1002%2FDA.20086

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluoxetine, comprehensive cognitive behavioral therapy, and placebo in generalized social phobia

1 reference

https://api.crossref.org/works/10.1002%2FDA.20086

7 January 2021

based on heuristic

inferred from DOI database lookup

The Brief Social Phobia Scale: a psychometric evaluation.

1 reference

https://api.crossref.org/works/10.1002%2FDA.20086

7 January 2021

based on heuristic

inferred from DOI database lookup

Successful treatment of facial blushing by endoscopic transthoracic sympathicotomy.

1 reference

https://api.crossref.org/works/10.1002%2FDA.20086

7 January 2021

based on heuristic

inferred from DOI database lookup

Estrogen raises the sweating threshold in postmenopausal women with hot flashes

1 reference

https://api.crossref.org/works/10.1002%2FDA.20086

7 January 2021

based on heuristic

inferred from DOI database lookup

Botulinum toxin A for axillary hyperhidrosis (excessive sweating).

1 reference

https://api.crossref.org/works/10.1002%2FDA.20086

7 January 2021

based on heuristic

inferred from DOI database lookup

Pathophysiology of sweating

1 reference

https://api.crossref.org/works/10.1002%2FDA.20086

7 January 2021

based on heuristic

inferred from DOI database lookup

Phenomenology of panic attacks: responsiveness of individual symptoms to imipramine

1 reference

https://api.crossref.org/works/10.1002%2FDA.20086

7 January 2021

based on heuristic

inferred from DOI database lookup

Paroxetine treatment of generalized social phobia (social anxiety disorder): a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FDA.20086

7 January 2021

based on heuristic

inferred from DOI database lookup

Sertraline treatment of generalized social phobia: a 20-week, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2FDA.20086

7 January 2021

based on heuristic

inferred from DOI database lookup

Psychopharmacological treatment of social phobia; a double blind placebo controlled study with fluvoxamine

1 reference

https://api.crossref.org/works/10.1002%2FDA.20086

7 January 2021

based on heuristic

inferred from DOI database lookup

Social fears and social phobia in a community sample of adolescents and young adults: prevalence, risk factors and co-morbidity.

1 reference

https://api.crossref.org/works/10.1002%2FDA.20086

7 January 2021

based on heuristic

inferred from DOI database lookup

Endoscopic versus transaxillary thoracic sympathectomy for primary axillary and palmar hyperhidrosis and/or facial blushing: 5-year-experience

1 reference

https://api.crossref.org/works/10.1002%2FDA.20086

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/DA.20086

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34561653&oldid=1871270898"